Cash Flow from Investing Activities: The total change in cash resulting from a company's investments.
Corcept Therapeutics Incorporated (CORT) had Cash Flow from Investing Activities of $4.54M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
$164.90M |
|
$-31.20M |
|
$2.88M |
|
$162.02M |
|
$214.50M |
|
$-49.60M |
|
$4.89M |
|
$-44.72M |
|
$-44.72M |
|
$-31.76M |
|
$-31.76M |
|
$-31.76M |
|
$-31.76M |
|
$-49.60M |
|
$-49.00M |
|
104.44M |
|
104.44M |
|
$-0.30 |
|
$-0.30 |
|
| Balance Sheet Financials | |
$426.03M |
|
$3.17M |
|
$388.85M |
|
$814.88M |
|
$149.19M |
|
-- |
|
$27.71M |
|
$176.89M |
|
$637.99M |
|
$637.99M |
|
$637.99M |
|
107.33M |
|
| Cash Flow Statement Financials | |
$-16.77M |
|
|
Cash Flow from Investing Activities |
$4.54M |
$0.76M |
|
$121.75M |
|
$109.99M |
|
$-11.76M |
|
$23.04M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.86 |
|
-- |
|
-- |
|
-- |
|
-- |
|
98.25% |
|
-30.08% |
|
-30.08% |
|
-- |
|
-27.12% |
|
-18.92% |
|
$-16.97M |
|
-- |
|
-- |
|
-- |
|
0.20 |
|
0.22 |
|
4.22 |
|
21.32 |
|
-4.98% |
|
-4.98% |
|
-3.90% |
|
-4.98% |
|
$5.94 |
|
$-0.16 |
|
$-0.16 |
|